Literature DB >> 21307213

Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.

Ewa Mosiej1, Ewa Augustynowicz, Monika Zawadka, Waldemar Dabrowski, Anna Lutyńska.   

Abstract

In the present study, clinical isolates of Bordetella pertussis collected in Poland from 1960 to 2005 were analyzed by pulsed-field gel electrophoresis (PFGE) according to protocols recommended in previous studies. Among the 110 isolates from 1995 to 2005, 59 PFGE patterns were found, most of which were different from those currently circulating in other European Union (EU) countries for which data are available. The PFGE patterns of currently disseminating B. pertussis clones were found within PFGE groups III and IV, as elsewhere in the EU, and in newly identified clusters A and C. Up to 70, 26, and 4%, respectively, of the currently isolated strains in Poland harbored ptxA1-prn1, ptxA1-prn2, and ptxA1-prn3 allele combinations, and most (82%) were found to be of the Fim2 phenotype. Differences in the extent of heterogeneity estimated by PFGE typing in B. pertussis populations circulating in Poland in comparison to other EU countries may be due to the different vaccine composition strategy, since routine pertussis vaccination was initiated in Poland in 1960.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307213      PMCID: PMC3122874          DOI: 10.1128/JCM.01487-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.

Authors:  Annika Elomaa; Abdolreza Advani; Declan Donnelly; Mia Antila; Jussi Mertsola; Hans Hallander; Qiushui He
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.

Authors:  Olga Borisova; Svetlana Yu Kombarova; Nelli S Zakharova; Marjolein van Gent; Vladimir A Aleshkin; Isabella Mazurova; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

3.  Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype.

Authors:  Abdolreza Advani; Lennart Gustafsson; Rose-Marie Carlsson; Declan Donnelly; Hans O Hallander
Journal:  APMIS       Date:  2007-06       Impact factor: 3.205

4.  Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis.

Authors:  Hans Hallander; Abdolreza Advani; Marion Riffelmann; Carl H W von König; Valerie Caro; Nicole Guiso; Frits R Mooi; Anna Gzyl; Margit S Kaltoft; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

5.  Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.

Authors:  David J Litt; Shona E Neal; Norman K Fry
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

6.  Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas.

Authors:  Elisabeth Njamkepo; Thomas Cantinelli; Ghislaine Guigon; Nicole Guiso
Journal:  Microbes Infect       Date:  2008-10-17       Impact factor: 2.700

7.  Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan.

Authors:  Hyun-Ja Han; Kazunari Kamachi; Kenji Okada; Hiromi Toyoizumi-Ajisaka; Yuko Sasaki; Yoshichika Arakawa
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

Review 8.  Bordetella pertussis strain variation and evolution postvaccination.

Authors:  Teemu Kallonen; Qiushui He
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

9.  Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Authors:  Eriikka Heikkinen; Dorothy K Xing; Rose-Marie Olander; Jukka Hytönen; Matti K Viljanen; Jussi Mertsola; Qiushui He
Journal:  BMC Microbiol       Date:  2008-09-25       Impact factor: 3.605

10.  Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains.

Authors:  Audrey J King; Tamara van Gorkom; Jeroen L A Pennings; Han G J van der Heide; Qiushui He; Dimitri Diavatopoulos; Kees Heuvelman; Marjolein van Gent; Karin van Leeuwen; Frits R Mooi
Journal:  BMC Genomics       Date:  2008-06-30       Impact factor: 3.969

View more
  10 in total

1.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Authors:  Abdolreza Advani; Hans O Hallander; Tine Dalby; Karen Angeliki Krogfelt; Nicole Guiso; Elisabeth Njamkepo; Carl Heinz Wirsing von Könnig; Marion Riffelmann; Frits R Mooi; Per Sandven; Anna Lutynska; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

2.  Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.

Authors:  E Mosiej; M Zawadka; K Krysztopa-Grzybowska; M Polak; E Augustynowicz; K Piekarska; A Lutyńska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-05       Impact factor: 3.267

3.  Bordetella pertussis population changes under whole-cell and acellular pertussis vaccines-induced immunity selection pressure in Poland.

Authors:  Maciej Polak; Ewa Mosiej; Marta Prygiel; Aleksandra A Zasada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-14       Impact factor: 5.103

4.  Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

Authors:  M van Gent; C J Heuvelman; H G van der Heide; H O Hallander; A Advani; N Guiso; C H Wirsing von Kőnig; D F Vestrheim; T Dalby; N K Fry; D Pierard; L Detemmerman; J Zavadilova; K Fabianova; C Logan; A Habington; M Byrne; A Lutyńska; E Mosiej; C Pelaz; K Gröndahl-Yli-Hannuksela; A M Barkoff; J Mertsola; A Economopoulou; Q He; F R Mooi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-20       Impact factor: 3.267

5.  Genome diversity and evolutionary characteristics of clinical isolates of Bordetella pertussis circulating in Iran.

Authors:  Samaneh Saedi; Azadeh Safarchi; Mojtaba Noofeli; Keyvan Tadayon; Alfred Chin Yen Tay; Binit Lamichhane; Hamzeh Rahimi; Fereshteh Shahcheraghi
Journal:  Iran J Microbiol       Date:  2020-02

6.  Comparative genomics of whole-cell pertussis vaccine strains from India.

Authors:  Shweta Alai; Vikas C Ghattargi; Manish Gautam; Krunal Patel; Shrikant P Pawar; Dhiraj P Dhotre; Umesh Shaligram; Sunil Gairola
Journal:  BMC Genomics       Date:  2020-05-07       Impact factor: 3.969

7.  Characterization of Bordetella pertussis Strains Isolated from India.

Authors:  Shweta Alai; Manish Gautam; Sonali Palkar; Jitendra Oswal; Sunil Gairola; Dhiraj P Dhotre
Journal:  Pathogens       Date:  2022-07-14

8.  Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran.

Authors:  Vajiheh Sadat Nikbin; Nazanin Jannesar Ahmadi; Maryam Hosseinpour; Masoumeh Nakhost Lotfi; Fahimeh Shooraj; Fatemeh Sadeghpour; Fereshteh Shahcheraghi
Journal:  Int J Mol Cell Med       Date:  2015

9.  Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients.

Authors:  Faezeh Haghighi; Fereshteh Shahcheraghi; Ebrahim Abbasi; Seyed Saeed Eshraghi; Hojjat Zeraati; Seyed Ali Javad Mousavi; Hossein Asgarian-Omran; Masoumeh Douraghi; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2014-07

10.  Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.

Authors:  Marta Prygiel; Ewa Mosiej; Karol Wdowiak; Paulina Górska; Maciej Polak; Klaudia Lis; Katarzyna Krysztopa-Grzybowska; Aleksandra Anna Zasada
Journal:  Med Microbiol Immunol       Date:  2021-08-02       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.